Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"610"
topic_facet:"Phase: Phase 4"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+4%22&lookfor=%22Chronic+respiratory+diseases%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+4%22&lookfor=%22Chronic+respiratory+diseases%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+4%22&lookfor=%22Chronic+respiratory+diseases%22&type=Subject
PubPharm (4)
1
Efficacy of hypertonic saline irrigation for nasal symptoms in children with perennial allergic rhinitis: A randomized double-blind study : Efficacy of hypertonic saline irrigation for nasal symptoms in children with perennial allergic rhinitis : A randomized double-blind study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Efficacy of hypertonic saline irrigation for nasal symptoms in children with perennial allergic rhinitis: A randomized double-blind study : Efficacy of hypertonic saline irrigation for nasal symptoms in children with perennial allergic rhinitis : A randomized double-blind study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study comparing whether the new drug comprising fluticasone propionate and salmeterol doses of 125µg and 25µg HFA MDI inhaler (spray pressure) applied two puffs twice daily is not less effective than the dose of 500µg / 50µg applied one puff twice daily as powder inhaler (DPI) in patients with asthma : The efficacy and safety of new formulation of combination of fluticasone propionate / salmeterol (125µg / 25µg) in MDI HFA inhaler compared with the reference drug at a dose of 500µg / 50µg in DPI (dry powder inhaler) type disc in patients with chronic asthma - COMBO-Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
A study comparing whether the new drug comprising fluticasone propionate and salmeterol doses of 125µg and 25µg HFA MDI inhaler (spray pressure) applied two puffs twice daily is not less effective than the dose of 500µg / 50µg applied one puff twice daily as powder inhaler (DPI) in patients with asthma : The efficacy and safety of new formulation of combination of fluticasone propionate / salmeterol (125µg / 25µg) in MDI HFA inhaler compared with the reference drug at a dose of 500µg / 50µg in DPI (dry powder inhaler) type disc in patients with chronic asthma - COMBO-Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: 610
Filter aufheben
Thema: Phase: Phase 4
Medienart
4
Aufsätze
4
E-Artikel
4
E-Ressourcen
Zeitschriftentitel
4
WHO International Clinical Trials Registry Plat...
Thema
610
Phase: Phase 4
4
Recruitment Status: Not yet recruiting
4
Study Type: Interventional
2
Medical Condition: Allergic rhinitis (AR) is on...
2
Medical Condition: Asthma is a common, chronic ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
2
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4
Englisch
Haven't found what you're looking for?
Wird geladen...